327 related articles for article (PubMed ID: 26790611)
1. Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery.
El Hoshy K; Bosseila M; El Sharkawy D; Sobhi R
Photodiagnosis Photodyn Ther; 2016 Jun; 14():4-8. PubMed ID: 26790611
[TBL] [Abstract][Full Text] [Related]
2. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
[TBL] [Abstract][Full Text] [Related]
3. Photodetection of basal cell carcinoma using methyl 5-aminolaevulinate-induced protoporphyrin IX based on fluorescence image analysis.
Won Y; Hong SH; Yu HY; Kwon YH; Yun SJ; Lee SC; Lee JB
Clin Exp Dermatol; 2007 Jul; 32(4):423-9. PubMed ID: 17459066
[TBL] [Abstract][Full Text] [Related]
4. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
Lee CY; Kim KH; Kim YH
Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
[TBL] [Abstract][Full Text] [Related]
6. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma--new aspects of diagnosis and treatment.
Wennberg AM
Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fluorescence diagnosis-guided Mohs micrographic surgery for pigmented vs non-pigmented basal cell carcinoma.
Jeon SY; Kim KH; Song KH
Acta Derm Venereol; 2014 Sep; 94(5):568-73. PubMed ID: 24448667
[TBL] [Abstract][Full Text] [Related]
10. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography for margin definition of basal cell carcinoma before micrographic surgery-recommendations regarding the marking and scanning technique.
De Carvalho N; Schuh S; Kindermann N; Kästle R; Holmes J; Welzel J
Skin Res Technol; 2018 Feb; 24(1):145-151. PubMed ID: 29057513
[TBL] [Abstract][Full Text] [Related]
12. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
13. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
14. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
15. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
16. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
17. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
Florell SR; Layfield LJ; Gerwels JW
J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome.
Muller FM; Dawe RS; Moseley H; Fleming CJ
Dermatol Surg; 2009 Sep; 35(9):1349-54. PubMed ID: 19500127
[TBL] [Abstract][Full Text] [Related]
19. Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.
Ro KW; Seo SH; Son SW; Kim IH
Ann Dermatol; 2011 Aug; 23(3):276-81. PubMed ID: 21909195
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]